These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15527447)

  • 1. The FABP2 gene polymorphism in cerebrovascular disease.
    Wanby P; Palmquist P; Rydén I; Brattström L; Carlsson M
    Acta Neurol Scand; 2004 Dec; 110(6):355-60. PubMed ID: 15527447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women.
    Albala C; Santos JL; Cifuentes M; Villarroel AC; Lera L; Liberman C; Angel B; Pérez-Bravo F
    Obes Res; 2004 Feb; 12(2):340-5. PubMed ID: 14981227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability.
    Helwig U; Rubin D; Klapper M; Li Y; Nothnagel M; Fölsch UR; Döring F; Schreiber S; Schrezenmeir J
    Metabolism; 2007 Jun; 56(6):723-31. PubMed ID: 17512303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort.
    Fisher E; Li Y; Burwinkel B; Kühr V; Hoffmann K; Möhlig M; Spranger J; Pfeiffer A; Boeing H; Schrezenmeir J; Döring F
    Horm Metab Res; 2006 May; 38(5):341-5. PubMed ID: 16718632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of genotype frequencies of ANP 664G/A polymorphism in normal subjects and CVD patients, and its association with plasma ANP levels].
    Ohta A; Sonoda A; Yatabe Y; Takeshita E; Saito I; Ito D; Tanahashi N; Fukuuchi Y; Kikuchi H; Murata M; Watanabe K
    Rinsho Byori; 2002 Mar; 50(3):296-300. PubMed ID: 11985060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
    Buraczynska M; Bednarek-Skublewska A; Buraczynska K; Ksiazek A
    Cytokine; 2008 Dec; 44(3):361-5. PubMed ID: 19014891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.
    Sekuri C; Cam FS; Ercan E; Tengiz I; Sagcan A; Eser E; Berdeli A; Akin M
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):38-42. PubMed ID: 16088850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis: no evidence for the role of the common FABP2 A54T gene polymorphism.
    Wanby P; Nilsson I; Brudin L; Nyhammar I; Gustafsson I; Carlsson M
    Acta Neurol Scand; 2007 Feb; 115(2):90-6. PubMed ID: 17212611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease.
    Freiberg JJ; Tybjaerg-Hansen A; Sillesen H; Jensen GB; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):990-6. PubMed ID: 18276912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
    Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
    Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between functional FABP2 promoter haplotype and type 2 diabetes.
    Li Y; Fisher E; Klapper M; Boeing H; Pfeiffer A; Hampe J; Schreiber S; Burwinkel B; Schrezenmeir J; Döring F
    Horm Metab Res; 2006 May; 38(5):300-7. PubMed ID: 16718625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of C1019T polymorphism in the connexin 37 gene and coronary artery disease in Chinese Han population].
    Han YL; Xi SY; Zhang XL; Yan CH; Yang Y; Kang J
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):100-4. PubMed ID: 17418016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
    Kouhkan F; Motovali-Bashi M; Hojati Z
    Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases].
    Peng X; Zhang L; Wang Q; Cui X
    Wei Sheng Yan Jiu; 2009 Jul; 38(4):401-4. PubMed ID: 19689066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile.
    Pérez-Bravo F; Fuentes M; Angel B; Sanchez H; Carrasco E; Santos JL; Lera L; Albala C
    Acta Diabetol; 2006 Dec; 43(4):93-8. PubMed ID: 17211557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
    Polonikov AV; Solodilova MA; Ivanov VP
    J Asthma; 2009 Jun; 46(5):523-8. PubMed ID: 19544176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
    Lu LH; Chen H; Yu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.